Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
15/4/2021
0:00
15:06
Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
Otros episodios de "JAMA Oncology Author Interviews"
No te pierdas ningún episodio de “JAMA Oncology Author Interviews”. Síguelo en la aplicación gratuita de GetPodcast.